Mase, S., Chorba, T., Parks, S., Belanger, A., Dworkin, F., Seaworth, B., . . . Shah, N. (2020). Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States. Clinical infectious diseases, 71(4), 1010. https://doi.org/10.1093/cid/ciz914
Chicago-Zitierstil (17. Ausg.)Mase, Sundari, Terence Chorba, Samuel Parks, Ann Belanger, Felicia Dworkin, Barbara Seaworth, Jon Warkentin, Pennan Barry, und Neha Shah. "Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States." Clinical Infectious Diseases 71, no. 4 (2020): 1010. https://doi.org/10.1093/cid/ciz914.
MLA-Zitierstil (9. Ausg.)Mase, Sundari, et al. "Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States." Clinical Infectious Diseases, vol. 71, no. 4, 2020, p. 1010, https://doi.org/10.1093/cid/ciz914.